Senti Biosciences, Inc.
SNTI
$1.65
$0.0553.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -58.32M | -54.79M | -52.79M | -70.90M | -56.95M |
| Total Depreciation and Amortization | 4.76M | 4.82M | 4.88M | 4.89M | 5.24M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.36M | 3.77M | 1.43M | 18.54M | 366.00K |
| Change in Net Operating Assets | -1.30M | 2.44M | 5.09M | 12.53M | 8.90M |
| Cash from Operations | -48.49M | -43.77M | -41.40M | -34.93M | -42.44M |
| Capital Expenditure | -207.00K | -11.00K | -26.00K | -19.00K | -1.88M |
| Sale of Property, Plant, and Equipment | 72.00K | 60.00K | 60.00K | 165.00K | 105.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 23.00M |
| Cash from Investing | -135.00K | 49.00K | 34.00K | 146.00K | 21.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -23.00K | -46.00K |
| Issuance of Common Stock | 49.59M | 49.06M | 49.06M | 589.00K | 579.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.73M | 4.26M | 4.67M | 2.43M | -- |
| Cash from Financing | 54.33M | 53.32M | 53.73M | 3.00M | 533.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.70M | 9.60M | 12.37M | -31.79M | -20.68M |